|
| Case | Age (years) | Gender | Comorbidities or risk factors | Affected valve | Surgery | Antibiotic regimen and duration | Survived? |
|
| 1 [16] | 69 | M | Cystoscopy | Aortic | No | Beta-lactam and aminoglycoside for 6 weeks | Yes |
| 2 [17] | 54 | M | Phimosis | Mitral | Yes | Beta-lactam for 6 weeks | Yes |
| 3 [18] | 43 | M | Untreated hepatitis C | Aortic | No | Beta-lactam and aminoglycoside for 5 days | No |
| 4 [19] | 68 | M | Indwelling urinary catheter | Aortic | Yes | Beta-lactam 6 weeks and aminoglycoside for 2 weeks | Yes |
| 5 [20] | 80 | M | Nonurologic malignancy | Aortic | Yes | Beta-lactam for 2 weeks | Yes |
| 6 [21] | 77 | M | Benign prostatic hypertrophy | Aortic | No | Beta-lactam and vancomycin; duration not reported | No |
| 7 [22] | 68 | M | Benign prostatic hypertrophy | Mitral | No | Beta-lactam for 3 weeks; oral aminoglycoside duration not reported | Yes |
| 8 [23] | 75 | M | Cystoscopy | Aortic | Yes | Beta-lactam and aminoglycoside for 6 weeks | Yes |
| 9 [24] | 89 | M | Transurethral resection of prostate | Mitral | No | Beta-lactam and aminoglycoside for 7 days | No |
| 10 [25] | 81 | M | Recurrent UTIs | Aortic | No | Beta-lactam 2 weeks and aminoglycoside for 8 days | No |
| 11 [26] | 42 | M | None | Aortic | Yes | Beta-lactam and aminoglycoside for 6 weeks | Yes |
| 12 [27] | 49 | M | Not reported | Aortic | Not reported | Beta-lactam and aminoglycoside; duration not reported | Yes |
| 13 [28] | 54 | M | Urethral stricture | Tricuspid and aortic | No | Beta-lactam and aminoglycoside; duration not reported | No |
| 14 [29] | 69 | M | Nonurologic malignancy | Aortic | Yes | Beta-lactam for 12 weeks | Yes |
| 15 [30] | 62 | M | Benign prostatic hypertrophy | Mitral and aortic | Yes | Beta-lactam and rifampin for 6 weeks and aminoglycoside for 2 weeks | Yes |
| 16 [31] | 78 | M | Aortic stenosis | Aortic | No | Beta-lactam and aminoglycoside for 10 days | No |
| 17 [32] | 74 | M | Benign prostatic hypertrophy | Mitral | Yes | Beta-lactam and aminoglycoside for 4 weeks | No |
| 18 [33] | 81 | M | Benign prostatic hypertrophy | Mitral | No | Beta-lactam and aminoglycoside for 6 weeks | Yes |
| 19 [33] | 78 | M | Indwelling urinary catheter | Aortic | No | Beta-lactam; duration not reported | No |
| 20 [33] | 87 | M | Benign prostatic hypertrophy | Mitral | No | Not reported | No |
| 21 [33] | 78 | F | Ureteral stent | Aortic | No | Beta-lactam and vancomycin for 2 weeks | No |
| 22 [34] | 48 | M | Atrial septal defect | Mitral | No | Beta-lactam and aminoglycoside; duration not reported | Yes |
| 23 [34] | 79 | F | Recurrent UTIs | Aortic | No | Beta-lactam and aminoglycoside for 6 weeks | Yes |
| 24 [35] | 91 | M | Indwelling urinary catheter | Mitral | Not reported | Beta-lactam for 4 weeks and aminoglycoside for 10 days | Yes |
| 25 [35] | 91 | M | Benign prostatic hypertrophy | Mitral | Not reported | Beta-lactam 4 weeks and aminoglycoside for 10 days | Yes |
| 26 [35] | 89 | F | Not reported | Mitral | Not reported | Beta-lactam 4 weeks and aminoglycoside for 10 days | Yes |
| 27 [35] | 86 | M | Urethral stricture | Aortic | Not reported | Beta-lactam 4 weeks and aminoglycoside for 10 days | Yes |
| 28 [35] | 83 | M | Urethral stricture | Mitral | Not reported | Beta-lactam 4 weeks and aminoglycoside for 10 days | Yes |
| 29 [35] | 80 | F | Not reported | Mitral | Not reported | Beta-lactam 4 weeks and aminoglycoside for 10 days | Yes |
| 30 [35] | 77 | M | Not reported | Aortic | Not reported | Beta-lactam for 4 weeks and aminoglycoside for 10 days | Yes |
| 31 [35] | 75 | M | Benign prostatic hypertrophy | Mitral | Not reported | Beta-lactam for 4 weeks and aminoglycoside for 10 days | Yes |
| 32 [35] | 74 | M | Suprapubic catheter | Not reported | Not reported | Beta-lactam for 4 weeks and aminoglycoside for 10 days | Yes |
| 33 [35] | 65 | M | Indwelling urinary catheter | Mitral | Not reported | Beta-lactam for 4 weeks and aminoglycoside for 10 days | Yes |
| 34 [35] | 53 | M | None | Aortic | Not reported | Beta-lactam 4 weeks and aminoglycoside for 10 days | Yes |
| 35 [35] | 49 | F | Intermittent urinary catheter | Aortic | Not reported | Beta-lactam for 4 weeks and aminoglycoside for 10 days | Yes |
| 36 [35] | 81 | M | Indwelling urinary catheter | Mitral | Not reported | Beta-lactam for 4 weeks and aminoglycoside for 10 days | Yes |
| 37 [35] | 74 | F | Nonurologic malignancy | Not reported | Not reported | Beta-lactam for 4 weeks and aminoglycoside for 10 days | Yes |
| 38 [36] | 87 | M | Nonurologic malignancy | Mitral | Not reported | Beta-lactam and aminoglycoside; duration not reported | No |
| 39 [36] | 77 | M | Liver failure | Aortic | Not reported | Beta-lactam and aminoglycoside; duration not reported | Yes |
| 40 [36] | 83 | M | Indwelling urinary catheter | Mitral | Not reported | Beta-lactam and aminoglycoside; duration not reported | Yes |
| 41 [36] | 73 | M | Suprapubic catheter | Not reported | Not reported | Beta-lactam and aminoglycoside; duration not reported | No |
| 42 [36] | 88 | F | Aortic stenosis | Aortic | Not reported | Beta-lactam and aminoglycoside; duration not reported | Yes |
| 43 [8] | 43 | M | Indwelling urinary catheter | Mitral | Yes | Beta-lactam and aminoglycoside for 6 weeks | Yes |
| 44 [37] | 49 | M | Phimosis and recurrent UTIs | Mitral | Yes | Beta-lactam and aminoglycoside for 5 days | No |
| 45 [38] | 84 | M | Pacemaker and nonurologic malignancy | Pacemaker | Yes | Beta-lactam for 6 weeks | Yes |
| Present case | 55 | M | None | Mitral | Yes | Beta-lactam and aminoglycoside for 6 weeks | Yes |
|
